|
1
|
Nakawah MO, Hawkins C and Barbandi F:
Asthma, chronic obstructive pulmonary disease (COPD), and the
overlap syndrome. J Am Board Fam Med. 26:470–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papaiwannou A, Zarogoulidis P, Porpodis K,
Spyratos D, Kioumis I, Pitsiou G, Pataka A, Tsakiridis K, Arikas S,
Mpakas A, et al: Asthma-chronic obstructive pulmonary disease
overlap syndrome (ACOS): Current literature review. J Thorac Dis. 6
Suppl 1:S146–S151. 2014.PubMed/NCBI
|
|
3
|
Zalewska M, Furmańczyk K, Jaworski S,
Niemiro W and Samoliński B: The prevalence of asthma and declared
asthma in Poland on the basis of ECAP survey using correspondence
analysis. Comput Math Methods Med. 2013:5978452013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tam A, Wadsworth S, Dorscheid D, Man SF
and Sin DD: The airway epithelium: More than just a structural
barrier. Ther Adv Respir Dis. 5:255–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barbato A, Turato G, Baraldo S, Bazzan E,
Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM
and Saetta M: Epithelial damage and angiogenesis in the airways of
children with asthma. Am J Respir Crit Care Med. 174:975–981. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dorscheid DR, Wojcik KR, Sun S, Marroquin
B and White SR: Apoptosis of airway epithelial cells induced by
corticosteroids. Am J Respir Crit Care Med. 164:1939–1947. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holgate ST: The airway epithelium is
central to the pathogenesis of asthma. Allergol Int. 57:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kardos Z: Treatment of chronic obstructive
pulmonary disease with inhaled pharmacotherapy: Role of
corticosteroids. Acta Pharm Hung. 82:33–41. 2012.(In Hungarian).
PubMed/NCBI
|
|
9
|
Spangler DL: The role of inhaled
corticosteroids in asthma treatment: A health economic perspective.
Am J Manag Care. 18 2 Suppl:S35–S39. 2012.PubMed/NCBI
|
|
10
|
De Bosscher K, Vanden Berghe W and
Haegeman G: Mechanisms of anti-inflammatory action and of
immunosuppression by glucocorticoids: Negative interference of
activated glucocorticoid receptor with transcription factors. J
Neuroimmunol. 109:16–22. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davies L, Karthikeyan N, Lynch JT, Sial
EA, Gkourtsa A, Demonacos C and Krstic-Demonacos M: Cross talk of
signaling pathways in the regulation of the glucocorticoid receptor
function. Mol Endocrinol. 22:1331–1344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benayoun L, Letuve S, Druilhe A,
Boczkowski J, Dombret MC, Mechighel P, Megret J, Leseche G, Aubier
M and Pretolani M: Regulation of peroxisome proliferator-activated
receptor gamma expression in human asthmatic airways: Relationship
with proliferation, apoptosis, and airway remodeling. Am J Respir
Crit Care Med. 164:1487–1494. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wadsworth SJ, Nijmeh HS and Hall IP:
Glucocorticoids increase repair potential in a novel in vitro human
airway epithelial wounding model. J Clin Immunol. 26:376–387. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pearson G, Robinson F, Gibson Beers T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Montiel M, Quesada J and Jiménez E:
Activation of calcium-dependent kinases and epidermal growth factor
receptor regulate muscarinic acetylcholine receptor-mediated
MAPK/ERK activation in thyroid epithelial cells. Cell Signal.
19:2138–2146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lind CR, Gray CW, Pearson AG, Cameron RE,
O'Carroll SJ, Narayan PJ, Lim J and Dragunow M: The
mitogen-activated/extracellular signal-regulated kinase kinase 1/2
inhibitor U0126 induces glial fibrillary acidic protein expression
and reduces the proliferation and migration of C6 glioma cells.
Neuroscience. 141:1925–1933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ayroldi E, Zollo O, Macchiarulo A, Di
Marco B, Marchetti C and Riccardi C: Glucocorticoid-induced leucine
zipper inhibits the Raf-extracellular signal-regulated kinase
pathway by binding to Raf-1. Mol Cell Biol. 22:7929–7941. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rhen T and Cidlowski JA: Antiinflammatory
action of glucocorticoids-new mechanisms for old drugs. N Engl J
Med. 353:1711–1723. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dolušić E and Frédérick R: Indoleamine
2,3-dioxygenase inhibitors: A patent review (2008–2012). Expert
Opin Ther Pat. 23:1367–1381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Newton RC, Friedman SM and Scherle
PA: Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer
therapy. Curr Cancer Drug Targets. 9:938–952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herbert A, Ng H, Jessup W, Kockx M,
Cartland S, Thomas SR, Hogg PJ and Wargon O: Hypoxia regulates the
production and activity of glucose transporter-1 and indoleamine
2,3-dioxygenase in monocyte-derived endothelial-like cells:
possible relevance to infantile haemangioma pathogenesis. Br J
Dermatol. 164:308–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jasperson LK, Bucher C,
Panoskaltsis-Mortari A, Taylor PA, Mellor AL, Munn DH and Blazar
BR: Indoleamine 2,3-dioxygenase is a critical regulator of acute
graft-versus-host disease lethality. Blood. 111:3257–3265. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnson TS, Munn DH and Maria BL:
Modulation of tumor tolerance in primary central nervous system
malignancies. Clin Dev Immunol. 2012:9372532012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Romani L, Fallarino F, De Luca A,
Montagnoli C, D'Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti
MC, Grohmann U, et al: Defective tryptophan catabolism underlies
inflammation in mouse chronic granulomatous disease. Nature.
451:211–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Watcharanurak K, Zang L, Nishikawa M,
Yoshinaga K, Yamamoto Y, Takahashi Y, Ando M, Saito K, Watanabe Y
and Takakura Y: Effects of upregulated indoleamine 2, 3-dioxygenase
1 by interferon γ gene transfer on interferon γ-mediated antitumor
activity. Gene Ther. 21:794–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oxenkrug GF: Metabolic syndrome,
age-associated neuroendocrine disorders, and dysregulation of
tryptophan-kynurenine metabolism. Ann N Y Acad Sci. 1199:1–14.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Myint AM and Kim YK: Network beyond IDO in
psychiatric disorders: Revisiting neurodegeneration hypothesis.
Prog Neuropsychopharmacol Biol Psychiatry. 48:304–313. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zoga M, Oulis P, Chatzipanagiotou S,
Masdrakis VG, Pliatsika P, Boufidou F, Foteli S, Soldatos CR,
Nikolaou C and Papageorgiou C: Indoleamine 2,3-dioxygenase and
immune changes under antidepressive treatment in major depression
in females. In Vivo. 28:633–638. 2014.PubMed/NCBI
|
|
30
|
Dunnill MS, Massarella GR and Anderson JA:
A comparison of the quantitative anatomy of the bronchi in normal
subjects, in status asthmaticus, in chronic bronchitis, and in
emphysema. Thorax. 24:176–179. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Boer WI, Sharma HS, Baelemans SM,
Hoogsteden HC, Lambrecht BN and Braunstahl GJ: Altered expression
of epithelial junctional proteins in atopic asthma: Possible role
in inflammation. Can J Physiol Pharmacol. 86:105–112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kicic A, Sutanto EN, Stevens PT, Knight DA
and Stick SM: Intrinsic biochemical and functional differences in
bronchial epithelial cells of children with asthma. Am J Respir
Crit Care Med. 174:1110–1118. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trautmann A, Kruger K, Akdis M,
Muller-Wening D, Akkaya A, Brocker EB, Blaser K and Akdis CA:
Apoptosis and loss of adhesion of bronchial epithelial cells in
asthma. Int Arch Allergy Immunol. 138:142–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hackett TL, Warner SM, Stefanowicz D,
Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick
SM, Bai TR and Knight DA: Induction of epithelial-mesenchymal
transition in primary airway epithelial cells from patients with
asthma by transforming growth factor-beta1. Am J Respir Crit Care
Med. 180:122–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stevens PT, Kicic A, Sutanto EN, Knight DA
and Stick SM: Dysregulated repair in asthmatic paediatric airway
epithelial cells: The role of plasminogen activator inhibitor-1.
Clin Exp Allergy. 38:1901–1910. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
MacKenzie CR, Heseler K, Müller A and
Däubener W: Role of indoleamine 2,3-dioxygenase in antimicrobial
defence and immuno-regulation: Tryptophan depletion versus
production of toxic kynurenines. Curr Drug Metab. 8:237–244. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Litzenburger UM, Opitz CA, Sahm F,
Rauschenbach KJ, Trump S, Winter M, Ott M, Ochs K, Lutz C, Liu X,
et al: Constitutive IDO expression in human cancer is sustained by
an autocrine signaling loop involving IL-6, STAT3 and the AHR.
Oncotarget. 5:1038–1051. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Munn DH, Sharma MD, Hou D, Baban B, Lee
JR, Antonia SJ, Messina JL, Chandler P, Koni PA and Mellor AL:
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic
cells in tumor-draining lymph nodes. J Clin Invest. 114:280–290.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yeung AW, Terentis AC, King NJ and Thomas
SR: Role of indoleamine 2,3-dioxygenase in health and disease. Clin
Sci (Lond). 129:601–672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aldajani WA, Salazar F, Sewell HF, Knox A
and Ghaemmaghami AM: Expression and regulation of immune-modulatory
enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial
cells and its effect on T cell activation. Oncotarget.
7:57606–57617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guilbert TW, Morgan WJ, Zeiger RS, Mauger
DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr, Strunk
RC, Allen DB, et al: Long-term inhaled corticosteroids in preschool
children at high risk for asthma. N Engl J Med. 354:1985–1997.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu J, Zhang M, Niu C, Luo Z, Dai J, Wang
L, Liu E and Fu Z: Dexamethasone inhibits repair of human airway
epithelial cells mediated by glucocorticoid-induced leucine zipper
(GILZ). PLoS One. 8:e607052013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Baybutt RC, Smith BW, Donskaya EV, Hu L,
Li T and Wang W: The proliferative effects of retinoic acid on
primary cultures of adult rat type II pneumocytes depend upon cell
density. In Vitro Cell Dev Biol Anim. 46:20–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miller LA, Cheng LZ and Wu R: Inhibition
of epidermal growth factor-like growth factor secretion in
tracheobronchial epithelial cells by vitamin A. Cancer Res.
53:2527–2533. 1993.PubMed/NCBI
|
|
45
|
Wesley UV, Bove PF, Hristova M, McCarthy S
and van der Vliet A: Airway epithelial cell migration and wound
repair by ATP-mediated activation of dual oxidase 1. J Biol Chem.
282:3213–3220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shim EJ, Chun E, Lee HS, Bang BR, Kim TW,
Cho SH, Min KU and Park HW: The role of high-mobility group box-1
(HMGB1) in the pathogenesis of asthma. Clin Exp Allergy.
42:958–965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takikawa O, Yoshida R, Kido R and Hayaishi
O: Tryptophan degradation in mice initiated by indoleamine
2,3-dioxygenase. J Biol Chem. 261:3648–3653. 1986.PubMed/NCBI
|
|
48
|
An XJ, Bai CX, Xia JB, Dang T, Qian P,
Qian GS and Liao W: Immature dendritic cells expressing indoleamine
2,3-dioxygenase suppress ovalbumin-induced allergic airway
inflammation in mice. J Investig Allergol Clin Immunol. 21:185–192.
2011.PubMed/NCBI
|
